Safety/efficacy trial using stored serum samples to investigate the immunogenicity of insulin aspart and soluble human insulin in children and adolescents from onset of type 1 diabetes

Trial Profile

Safety/efficacy trial using stored serum samples to investigate the immunogenicity of insulin aspart and soluble human insulin in children and adolescents from onset of type 1 diabetes

Completed
Phase of Trial: Phase III

Latest Information Update: 24 Dec 2016

At a glance

  • Drugs Insulin aspart (Primary) ; Insulin
  • Indications Type 1 diabetes mellitus
  • Focus Pharmacodynamics
  • Sponsors Novo Nordisk
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 15 Jun 2012 Actual patient number is 74 as reported by ClinicalTrials.gov.
    • 15 Jun 2012 Actual end date (1 May 2006) added as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top